全国服务热线: 0771-3153914

Chinese            English

Production address: No. 2, Zhongyu South Road, Xixiangtang District, Nanning City

Prescription Division:18688151943 

Over-the-counter division:18688151943

Copyright:Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.         桂公网安备 45010502000886号     桂ICP备20003205号-1  Powered by www.300.cn            This site supports IPv6

>
Introduction
Page view:

Guangxi nanning baihui pharmaceutical group co. LTD

 

Guangxi nanning hundred pharmaceutical group co., LTD. (hereinafter referred to as "hundreds of pharmaceutical industry") is located in nanning city xixiang YaoNa road no. 2 in the pond area, is a production and sales, in the western medicine preparations, chemical pharmaceuticals, mainly production of guangxi minorities "strong medicine" pharmaceutical enterprise, also is the stomach medicine production base, in a pivotal position in the pharmaceutical industry in guangxi.

 

The company was founded in 1934, has more than 80 years of pharmaceutical history. Its predecessor, guangxi no.1 pharmaceutical factory, was the first government-run pharmaceutical factory in guangxi established by the guangxi provincial government in wuzhou city, and also the earliest pharmaceutical enterprise in guangxi to produce and sell Chinese patent medicine, chemical medicine and raw material medicine. Later, it moved to nanning city and changed its name to nanning pharmaceutical factory.

 

In January 1991, nanning pharmaceutical factory, nanning pharmaceutical second factory, nanning traditional Chinese medicine factory and nanning building decoration material factory were merged and reorganized into nanning pharmaceutical enterprise group company of guangxi zhuang autonomous region, which was a large state-owned second-class enterprise.

 

In September 2000, the company changed its name to guangxi nanning baihui pharmaceutical group co., LTD.

 

In May 2014, "baihui pharmaceutical" was wholly controlled by guangxi fengye investment co., LTD.

 

At present, "baihui pharmaceutical" all production workshops have been GMP certification. Company product variety is complete, is based on basic drugs, the "strong medicine" as the characteristics of the pharmaceutical production structure system, can produce tablet, capsule, granule, powder, syrup, oral solution, oral suspension agent, gels, mixture, lozenge, small volume injection dosage forms and apis 14 244 varieties, of which 72 varieties for the 2018 edition of national essential drugs, 10 varieties for the 2012 edition of guangxi supplement essential medicines, 144 varieties in the nation's health care drugs, 166 varieties of guangxi medical insurance drugs, The product treatment scope includes digestive system, cardiovascular and cerebrovascular, orthopedics, respiratory system, children's medicine, health care and other fields. Reasonable product structure, stable quality, trusted by patients. Several products, such as glucose injection and inosine oral solution, have won the title of famous brand in guangxi zhuang autonomous region.

 

"Baihui pharmaceutical" has strong independent research and development ability, and has established the guangxi zhuang autonomous region level technical center -- "guangxi baihui pharmaceutical pharmaceutical research institute" and the national "zhuang medicine modernization research center of zhuang bone 3131 engineering center". We have obtained 16 patents and 9 new drug certificates. Over the years, we have adhered to the road of scientific and technological innovation, strengthened the cultivation of independent innovation ability, and promoted the development of enterprises by relying on technological progress and product research and development. In recent years, 10 national new drugs have been independently developed, among which aluminum magnesium carbonate suspension, jiangu injection, compound dendrobium granule, hair growth tablet and qufengtong tablet are the first in China. Jiangu injection and compound dendrobium fresh granule applied for national patent in 1994, and dendrobium fresh granule obtained the invention patent certificate in 2000. In recent years, through independent innovation, the company has completed the production application of acetyl-kitasamycin dispersive tablets and compound glycyrrhizin sodium chloride injection, 5 new chemical drugs, and 6 new chemical drugs xylitol injection, among which acetyl-kitasamycin dispersive tablets and compound glycyrrhizin sodium chloride injection are technological innovation projects of nanning. It has 28 registered trademarks such as "baihui", "ted" and "kanglilong", among which "baihui" is a famous trademark in guangxi. In 2014, baihui pharmaceutical was jointly awarded "high-tech enterprise" by guangxi department of science and technology, department of finance, national taxation bureau and local taxation bureau, and again awarded "high-tech enterprise" in 2018. It has been awarded by the state affairs commission as "top 100 enterprise of national ethnic trade and ethnic special commodity production".

 

"Hundreds of pharmaceutical" repeatedly been rated as advanced units of nanning (enterprise), obtain the nanning economic benefit "the center", "silver award", "copper cup prize" and nanning city "top ten" tax, tax contributions to enterprises, nanning "contract and keep credibility" enterprises such as title, is the national encouraged industry enterprises.

 

In 2014, in order to realize the strategic development of the enterprise and build a modern first-class pharmaceutical enterprise, "baihui pharmaceutical" started the construction of the new factory project in nanning national economic and technological development zone with 150 mu of new land (no. 39, jinyang road) under the care and support of the governments at all levels in the autonomous region and nanning.

 

The project covers a total area of 10,0001.95 square meters (150 mu), a total construction area of 77225.78 square meters, and a total investment of 775 million yuan. It mainly has TCM extraction workshop, comprehensive preparation workshop, solid preparation workshop, raw material medicine workshop and so on. At present, the workshop that has been put into production has TCM extraction workshop. It is expected to complete the GMP certification of each workshop and the relocation of the old factory in December this year.

 

After completion of the project, with an annual production capacity of 1.5 billion tablets respectively, 250 tons of granule, capsule 50 million grains, tower 50 million grain of sugar, oral liquid (below 20 ml), 100 million, 15 million bottles of oral liquid (more than 20 ml), small capacity injection, 160 million, 500 tons of active pharmaceutical ingredients, Chinese medicine extract 3000 tons of production capacity, sales income 1.5 billion yuan of above, pay taxes andprofits 300 million yuan.

 

The entry of guangxi nanning baihui pharmaceutical group co., LTD. Of fengye group will play a strong supporting and driving role for nanning jingkai district to further expand the biopharmaceutical industry, lengthen the biopharmaceutical industry chain, consolidate the development momentum, and enhance the economic aggregate of the park. The project construction is conducive to promoting the clustering development of guangxi pharmaceutical industry.